Molecular confirmation of Bacillus Calmette Guerin vaccine related adverse events among Saudi Arabian children
- PMID: 25409184
- PMCID: PMC4237431
- DOI: 10.1371/journal.pone.0113472
Molecular confirmation of Bacillus Calmette Guerin vaccine related adverse events among Saudi Arabian children
Abstract
Background: Bacillus Calmette Guerin (BCG) is the only available vaccine for tuberculosis (TB). Low grade complications in healthy recipients and disseminated vaccine associated complications among immuno-suppressed individuals were noticed globally after administration. Recently a series of clinically suspected BCG associated suppurative and non-suppurative lymphadenitis cases were reported from different regions of Saudi Arabia. However a molecular confirmative analysis was lacking to prove these claims.
Methodology: During 2009-2010, 42 Mycobacterium bovis BCG suspected clinical isolates from children diagnosed with suppurative lymphadenitis from different provinces of the country were collected and subjected to 24 loci based MIRU-VNTR typing, spoligotyping and first line anti-TB drugs susceptibility testing.
Principal findings: Of the total 42 cases, 41 (97.6%) were Saudi nationals and particularly male (64.3%). Majority of the cases were aged below 6 months (83.3%) with a median of age 4 months. All the enrolled subjects showed left axillary mass which suppurated in a median of 4 months after vaccination. Among the study subjects, 1 (2.4%) case was reactive to HIV antigen and 2 (4.8%) case had severe combined immunodeficiency. Genotyping results showed that, 41 (97.6%) isolates were identical to the vaccine strain Danish 1331 and one to Tokyo 172-1. Phylogenetic analysis revealed all the Danish 1331 isolates in a single cluster.
Conclusion: Elevated proportion of suppurative lymphadenitis caused by M. bovis BCG reported in the country recently is majorly related to the vaccine strain Danish 1331. However lack of nationwide data on real magnitude of BCG related adverse events warrants population centric, long term future studies.
Conflict of interest statement
Figures

Similar articles
-
Outbreak of Bacille Calmette-Guérin-related lymphadenitis in Saudi children at a university hospital after a change in the strain of vaccine.Ann Saudi Med. 2012 Jan-Feb;32(1):4-8. doi: 10.5144/0256-4947.2012.4. Ann Saudi Med. 2012. PMID: 22156633 Free PMC article.
-
Adverse reactions to the Bacillus Calmette-Guérin (BCG) vaccine in new-born infants-an evaluation of the Danish strain 1331 SSI in a randomized clinical trial.Vaccine. 2016 May 11;34(22):2477-82. doi: 10.1016/j.vaccine.2016.03.100. Epub 2016 Apr 7. Vaccine. 2016. PMID: 27060379 Clinical Trial.
-
Bacillus Calmette-Guérin vaccine complications in Iranian children at a University Hospital.Allergol Immunopathol (Madr). 2017 Jul-Aug;45(4):356-361. doi: 10.1016/j.aller.2016.10.006. Epub 2017 Feb 1. Allergol Immunopathol (Madr). 2017. PMID: 28161281
-
[HIV-infection, AIDS and BCG vaccination].Kekkaku. 1993 Jun;68(6):435-44. Kekkaku. 1993. PMID: 8341039 Review. Japanese.
-
Prospects in Mycobacterium bovis Bacille Calmette et Guérin (BCG) vaccine diversity and delivery: why does BCG fail to protect against tuberculosis?Vaccine. 2015 Sep 22;33(39):5035-41. doi: 10.1016/j.vaccine.2015.08.033. Epub 2015 Aug 28. Vaccine. 2015. PMID: 26319069 Free PMC article. Review.
Cited by
-
MIRU-profiler: a rapid tool for determination of 24-loci MIRU-VNTR profiles from assembled genomes of Mycobacterium tuberculosis.PeerJ. 2018 Jul 11;6:e5090. doi: 10.7717/peerj.5090. eCollection 2018. PeerJ. 2018. PMID: 30018852 Free PMC article.
-
Prophylactic vaccines are potent activators of monocyte-derived dendritic cells and drive effective anti-tumor responses in melanoma patients at the cost of toxicity.Cancer Immunol Immunother. 2016 Mar;65(3):327-39. doi: 10.1007/s00262-016-1796-7. Epub 2016 Feb 10. Cancer Immunol Immunother. 2016. PMID: 26861670 Free PMC article.
-
Disseminated Bacillus Calmette-Guérin (BCG) infections in infants with immunodeficiency.BMC Res Notes. 2017 May 5;10(1):177. doi: 10.1186/s13104-017-2499-7. BMC Res Notes. 2017. PMID: 28476145 Free PMC article.
-
Adverse reactions to Mycobacterium bovis bacille Calmette-Guérin vaccination against tuberculosis in Iranian children.Clin Exp Vaccine Res. 2015 Jul;4(2):195-9. doi: 10.7774/cevr.2015.4.2.195. Epub 2015 Jul 29. Clin Exp Vaccine Res. 2015. PMID: 26273579 Free PMC article.
-
Bacillus Calmette-Guérin Vaccine-Related Osteomyelitis in Immunocompetent Children in Saudi Arabia: A Narrative Review.Cureus. 2022 Dec 21;14(12):e32762. doi: 10.7759/cureus.32762. eCollection 2022 Dec. Cureus. 2022. PMID: 36570112 Free PMC article. Review.
References
-
- Behr MA, Wilson MA, Gill WP, Salamon H (1999) Schoolnik GK, et al (1999) Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science 284: 1520–1523. - PubMed
-
- Ritz N, Hanekom WA, Robins-Browne R, Britton WJ, Curtis N (2008) Influence of BCG vaccine strain on the immune response and protection against tuberculosis. FEMS Microbiol Rev 32: 821–841. - PubMed
-
- Turnbull FM, McIntyre PB, Achat HM, Wang H, Stapledon R, et al. (2002) National study of adverse reactions after vaccination with bacille Calmette-Guerin. Clin Infect Dis 34: 447–453. - PubMed
-
- Sadeghi-Shabestari M, Rezaei N (2009) Disseminated bacille Calmette–Guérin in Iranian children with severe combined immunodeficiency. Int J Infect Dis 13: e420–e423. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources